Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What is this, News from 2015? You can’t find a better way to pump this?
A crash has more chance than a liftoff!
Not with $100 Kalani Warrants!
I am amazed at what you are spewing out, there is $100 million Kalani Warrants are pending and you are trying to pump this? Do you really think that people buy stocks without looking at financials?
Dose anyone know the FDA meeting date?
Thank you Opti, I really appreciate your efforts to keep us informed.
Regardless of oil, the trading volume fell and that’s another risk factor to pay attention to.
Oil markets turned red and more red is expected with market sell off.
Buy the rumor Sell the News.
Warren buffet
Buy the rumor sell the news, that’s what happened today! ??
Short squeeze doesn’t happen with billion shares outstanding.
Jone received delisting notice, directors left with millions of free shares.
I hope they announced something positive about the phase 2 and then did the offerings but anyways, it is what it is! ??
But that didn’t happened either.
He will do his best to get this re listed, NEWC was his ATM how can he not want to reactivate his ATM?
A good opportunity to recover your loss is to go short when this failed business is listed on NASDAQ.
After the R/S the OS got really thin, and despite that the stock was shorted even more, but at that moment EPA required that gas should contain 15% ethanol instead of 10% with that news Gevo buy back started and that caused a massive squeeze and eventually the PPS skyrocketed. But soon the company announced another offering/dilution so with the availability of more shares in the market PPS tanked again. This recent rise is because of some insider share buy back and this will pass too.
What could be bigger than Oracle and Marketo? Both making 8k/ quarter which is amazing. Lol
Things look great only down from $3 to $0.42 not a big deal I guess. Lol
This over hipped turd is swirling down the toilet.
What news?
But what happened to disrupting Fusz technology? Why acquire another company with diluting the crap out of Fusz? Seems things are headed down the toilet.
Wait until this pos is up listed then short it to recover your loss.
Just can’t wait till this pos is listed on NASDAQ to short it to pennies from dollars.
Dilution and R/S to up-list will be next.
The only way to recover my loss with this POS is to wait until up-listing and then short it. A company with no revenue on NASDAQ gets shorted only.
Nothing can be expected until Q3, the stock had great runs, and hats off to those who made money on no news.
10-Q page 13 indicates:
Our Phase 2 trial for XBIO-101 commenced patient dosing in October 2017. We have experienced slower progress in our Phase 2 trial than originally estimated, and therefore are unable to predict when preliminary data from this trial may be available.
10-Q page 13 indicates:
Our Phase 2 trial for XBIO-101 commenced patient dosing in October 2017. We have experienced slower progress in our Phase 2 trial than originally estimated, and therefore are unable to predict when preliminary data from this trial may be available.
How much would be the reverse split ratio for up-listing?
Xbio keeps giving.
Unfortunately it will go down, until news comes out, but that will be a while.
And what’s the bottom you are waiting on?
Do you know what happens to share price of companies with little income on NASDAQ? It gets shorted to pennies from dollars!
And how is that possible with meager income and lots of dilution?
S-1 says the shares will be sold as discount to current market share price.
$20 millions worth of shares going to hit the market and we don’t know at what price?
If you read the 10-Q you will notice that the company has adequate cash on hand until Q3 and very responsible when it comes to curb expenses.
FDA orphan drug designation is not something to ignore!
Volume is unbelievable, it will be going much higher!